Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. 1994

R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
Sección de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Tumor necrosis factor alpha (TNF-alpha) is a multifunctional cytokine that has an important role in the pathogenesis of inflammation, cachexia, and septic shock. Although TNF-alpha is mainly produced by macrophages, there is evidence regarding TNF-alpha production by cells that are not derived from bone marrow. TNF-alpha production by normal and inflamed human liver was assessed at both mRNA and protein levels. Using a wide panel of novel anti-TNF-alpha monoclonal antibodies and a specific polyclonal antiserum, TNF-alpha immunoreactivity was found in hepatocytes from patients chronically infected with either hepatitis B virus (HBV) or hepatitis C virus. Minimal TNF-alpha immunoreactivity was detected in the mononuclear cell infiltrate and Kupffer cells. In situ hybridization experiments using a TNF-alpha RNA probe showed a significant expression of TNF-alpha mRNA in hepatocytes, Kupffer cells, and some infiltrating mononuclear cells. By contrast, TNF-alpha was detected at low levels in liver biopsies from normal individuals or patients with alcoholic liver disease and low expression of TNF-alpha mRNA was observed in these specimens. Transfection of HepG2 hepatoblastoma cells with either HBV genome or HBV X gene resulted in induction of TNF-alpha expression. Our results demonstrate that viral infection induces, both in vivo and in vitro, TNF-alpha production in hepatocytes, and indicate that the HBV X protein may regulate the expression of this cytokine. These findings suggest that TNF-alpha may have an important role in human liver diseases induced by viruses.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007728 Kupffer Cells Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood and dispose of worn out red blood cells. Kupffer Cell,Cell, Kupffer,Cells, Kupffer
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008104 Liver Cirrhosis, Alcoholic FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING. Alcoholic Cirrhosis,Hepatic Cirrhosis, Alcoholic,Alcoholic Hepatic Cirrhosis,Alcoholic Liver Cirrhosis
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
November 1990, Cytokine,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
January 1996, Zhonghua nei ke za zhi,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
July 1989, Cancer research,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
January 2001, European journal of obstetrics, gynecology, and reproductive biology,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
January 1998, Japanese journal of pharmacology,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
April 1998, Journal of periodontology,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
September 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
July 2011, Comparative immunology, microbiology and infectious diseases,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
February 1993, Journal of leukocyte biology,
R González-Amaro, and C García-Monzón, and L García-Buey, and R Moreno-Otero, and J L Alonso, and E Yagüe, and J P Pivel, and M López-Cabrera, and E Fernández-Ruiz, and F Sánchez-Madrid
May 1994, Infection and immunity,
Copied contents to your clipboard!